Methods for preventing, ameliorating or treating one or more symptoms of Hepatitis C virus (HCV), modulating HCV protease activity and/or inhibiting cathepsin activity in a subject, wherein the methods comprise administering to a subject in need of such treatment a dosage formulation containing at least one compound of Formulae (I) - XXVI herein, wherein the dosage formulation is capable of maintaining an average Cmin plasma concentration of the compound at or above 10ng/ml.
申请公布号
WO2006130552(A2)
申请公布日期
2006.12.07
申请号
WO2006US20732
申请日期
2006.05.31
申请人
SCHERING CORPORATION;GUPTA, SAMIR, K.;MALCOLM, BRUCE, A.